Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.
Since the blood and thymus of patients with myasthenia gravis may contain inhibitors of neuromuscular transmission that affect acetylcholine receptors of striated muscle, we used denervated rat muscle to test for inhibitors in 43 serums and 18 thymus glands from such patients. Seven per cent of serums inhibited the binding of 125l alpha-bungarotoxin to triton-solubilized receptors; 65 per cent interfered with binding of toxin-labeled receptors to concanavalin-A coupled to Sepharose gel, and 85 per cent formed IgG-receptor complexes detectable by immunoprecipitation. Serum inhibitory activity varied widely among patients with similar clinical manifestations and was not correlated with duration of myasthenia gravis or thymectomy. Among thymus extracts, 44 per cent were inhibitory in the concanavalin-A binding assay, whereas 72 per cent contained anti-receptor IgG. Thus, serums from patients with myasthenia gravis contain more than one anti-receptor factor.
D000109:Acetylcholine; D000818:Animals; D001323:Autoantibodies / Q000032:analysis*; D001327:Autoimmune Diseases; D001666:Binding Sites, Antibody; D002038:Bungarotoxins; D002845:Chromatography; D003208:Concanavalin A; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D008722:Methods; D009132:Muscles / Q000276:immunology; D009157:Myasthenia Gravis / Q000097:blood / Q000276:immunology* / Q000503:physiopathology; D051381:Rats; D011950:Receptors, Cholinergic; D013949:Thymus Extracts / Q000032:analysis; D013950:Thymus Gland / Q000276:immunology*
D001323:Autoantibodies; D002038:Bungarotoxins; D007074:Immunoglobulin G; D011950:Receptors, Cholinergic; D013949:Thymus Extracts; D003208:Concanavalin A; D000109:Acetylcholine